Advancing Skin Cancer Pathology With AI Image Analysis

By Author Proscia | March 27, 2020

Image analysis can be a painstaking process for skin cancer pathologists. Workloads are increasing, and the number of qualified pathologists is shrinking. New technologies are needed to relieve the pressure. Proscia, a Philadelphia-based software company, thinks their DermAI software could be part of the solution. DermAI has recently been put to the test in a validation study that analyzed over 13,000 images. We spoke with Nathan Buchbinder, Proscia’s CPO, to find out more.

New to digital pathology? Learn how whole slide imaging is changing the industry here.

Our website uses cookies. By using this site, you agree to its use of cookies.